About Accellix
Accellix is a company based in San Jose (United States) founded in 2007. Accellix has raised $35.84 million across 10 funding rounds from investors including BioMerieux, Broadoak Capital Partners and Axcel. Accellix offers products and services including Accellix Platform, Instrument and Software, Standard Assay Kits, Custom Assay Kits, and Algorithm-Based Autoanalysis. Accellix operates in a competitive market with competitors including Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
- Headquarter San Jose, United States
- SectorsHealthcare
- Phone•••• ••••
- Website accellix.com
- Social LinkedIn X YouTube
- Legal Name Accellix, Inc.
- Total Equity Funding$35.84M (USD)
in 10 rounds
- Latest Funding Round$10M (USD), Series D
Dec 2021
- InvestorsBioMerieux
& 2 more
Products & Services of Accellix
Accellix offers a comprehensive portfolio of products and services, including Accellix Platform, Instrument and Software, Standard Assay Kits, Custom Assay Kits, and Algorithm-Based Autoanalysis.
Automated bench-top platform for flow cytometry in GMP manufacturing.
Software for configurable data analysis in cell therapy workflows.
Kits that automate sample preparation for accurate phenotyping.
Tailored assays for specific research and manufacturing needs.
Tools for fully automated data analysis and classification.
Apps and channels of Accellix
its YouTube channel Accellix has 20 subscribers.
Funding Insights of Accellix
Accellix has successfully raised a total of $35.84M across 10 strategic funding rounds. The most recent funding activity was a Series D round of $10 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $35.84M
- Total Rounds 10
- Last Round Series D — $10M
- First Round $377,000
(Jul 2009)
- Investors Count 3
All 10 funding rounds of Accellix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2021 | $10M | Series D | – | Broadoak Capital Partners | – |
| Jul 2020 | $5M | Series D | – | – | – |
| Jun 2020 | $9.5M | Series D | – | BioMerieux | – |
| Jun 2014 | $7M | Series A | – | Axcel | – |
| Aug 2013 | $1.14M | Grant | – | – | – |
| Nov 2012 | $2M | Series A | – | Axcel | – |
| Apr 2012 | $1.6M | Seed | – | – | – |
| Aug 2010 | $250,000 | Seed | – | – | – |
| Jun 2010 | $115,000 | Seed | – | – | – |
| Jul 2009 | $377,000 | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Accellix
Accellix has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include BioMerieux, Broadoak Capital Partners and Axcel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investment banking services are offered in the United States. | 2006 | broadoak.com | Bethesda, United States | |
Developer of diagnostics devices for multiple health purposes | 1963 | biomerieux.com | - | |
Axcel is engaged in private equity investments for value creation. | – | axcel.dk | Copenhagen, Denmark |
Investor details for Accellix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Accellix
26 people are tracked at Accellix (10 in leadership, 16 in team).
| Name | Role | Group |
|---|---|---|
Nir Nimrodi | CEO | Leadership |
Nili Tshuva | Director Of Software | Leadership |
Michael Sherriff | Director of Sales, North America | Leadership |
Hiren Patel | Director Of Sales - EMEA & Global Key Accounts | Leadership |
William Cheng | Head Of Global Technical Support | Leadership |
Rey Mali | VP, Sales & Marketing | Leadership |
Zion Botesazan | Accellix Israel Site Lead, VP Hardware/software | Leadership |
Rey (Reut) Mali | Chief Operating Officer | Leadership |
Reed Hickey | VP, Product | Leadership |
Terrance Gin | VP, Global Operations | Leadership |
Jon Pustorino | Field Application Specialist | Team |
Judith Adelman | Software Engineer LabVIEW | Team |
Jinglebob Davis | Field Application Scientist | Team |
kyle danh | Senior Research Associate | Team |
Arthur Krigel | Data Scientist | Team |
Brian Gray | Field Application Manager | Team |
Charlene "Acata" Felton | Associate Scientist | Team |
Jason Luo | Field Applications Scientist | Team |
Jyothi J. | Staff Scientist and Team Lead | Team |
Michael Bazarsky | Associate Scientist | Team |
6 more people are available in the full profile.
Complete people profiles for Accellix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Accellix
3 dated milestones of Accellix across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Accellix is founded.
- Funding First funding round of $377K.
- Funding Latest funding round, Series D, of $10.0M.
Competitors of Accellix
Accellix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abingdon Health, Spear Bio, Olink, Virtue Diagnostics and Eclipse Bio, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| abingdonhealth.com | 2008 | York, United Kingdom | $24.05M | 151 | Developer of immunoassays for diagnostic purposes | |
| spear.bio | 2021 | Boston, United States | $48.96M | – | Developer of ultrasensitive immunoassays and proteomics platforms for detecting protein biomarkers | |
| olink.com | 2004 | Uppsala, Sweden | – | 138 | Provider of products and services for human protein biomarker research and development | |
| virtuedx.com | 2019 | Suzhou, China | $130M | – | An in vitro assay platform is provided for diagnostic solutions. | |
| eclipsebio.com | 2017 | San Diego, United States | $14M | 14 | Cell-free immunoassays are developed to identify RNA binding protein targets. | |
| correliabio.com | 2013 | Berkeley, United States | $10.95M | – | Correlia Biosystems is focused on protein quantification technology. | |
| usbiotek.com | 2008 | Shoreline, United States | $19.5M | – | Provider of enzyme-linked immunosorbent assay technology services | |
| remedybiologics.com | 2017 | Dublin, Ireland | $9.43M | – | Personalized cell-based autologous therapies for anti-tumor applications are provided. | |
| orbitdiscovery.com | 2015 | Oxford, United Kingdom | $15.73M | 26 | Drug discovery platform developed using peptide display engine. |
Detailed competitors of Accellix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Accellix
The website of Accellix (accellix.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 25.8% vs previous month
Latest news on Accellix
Complete news archive for Accellix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Accellix
10 companies that operate in the same segment as Accellix (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Accellix
Accellix was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Accellix is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Nir Nimrodi is the current CEO of Accellix.
Accellix is a funded company, having raised a total of $35.84M across 10 funding rounds to date. The company's 1st funding round was a Seed of $377K, raised on Jul 2009.
Accellix was founded in 2007 in San Jose, United States, within the biotechnology sector. Immunotherapy-based assay delivery platforms are developed, incorporating dry reagents and microfluidic cartridges. Bead assays, cell assays, and enzymatic PCR are provided as core offerings. Additional services include diluent processing, laser and optics integration, photon capture, electronics, and related components for assay applications.
Accellix's top competitors include Abingdon Health, Eclipse Bio and Spear Bio.
Accellix offers Accellix Platform, Instrument and Software, Standard Assay Kits, Custom Assay Kits, and Algorithm-Based Autoanalysis.
Accellix has 3 investors. Key investors include BioMerieux, Broadoak Capital Partners, and Axcel.
Accellix operates through Accellix, Inc..